Based on the semi-quantitative scoring results of TRIP13 protein via immunohistochemistry in HCC, we investigated the association between high and low levels of TRIP13 protein and clinicopathological parameters of patients. This evidence concerns the gene TRIP13 and hepatocellular carcinoma.